| [1] |
MA Yan, TIAN Gaopeng, SHI Xingwen, SUN Ting, XIE Jingjing, ZHEN Donghu.
Correlation between 25(OH)D and metabolically related fatty liver in T2DM population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1018-1026.
|
| [2] |
HOU Ruiying, GUO Lige, JIAO Weijie, DU Lei, WU Guiyue, ZHAO Xu.
Effects of Xiaokeshu recipe on levels of serum inflammatory factors in type2 diabetic rats and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 377-382.
|
| [3] |
ZHAI Weiwei, YU Qiaoling, LIU Ping, QIU Bo, WU Huizhen.
Research progress of finerenone in the treatment of type 2 diabetes mellitus complicated with chronic kidney disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1067-1074.
|
| [4] |
LU Senlin, LIU Xinyuan, WANG Jili, HUANG Xiaofei.
Research progress of virus-mediated gene therapy in type 2 diabetes mellitu
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 800-807.
|
| [5] |
DAI Hongyu, YANG Kun, HU Ruchun, ZHOU Hongmei, MA Peimin, HAO Qian.
Duration time and effectiveness of 0.25%ropivacaine for sciatic nerve block in patients with diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1278-1284.
|
| [6] |
WU Yi, FANG Fang, CHEN Ying, Fan Junwei.
Influence of donor and recipient CYP3A5 genotype on tacrolimus trough concentrations in the early stage after liver transplantation and its clinical significance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 631-639.
|
| [7] |
XU Yongxia, XIE Mingzhu, GONG Muxue, HUANG Jiaying, ZHAO Li, ZHU Defa.
Effects of 25(OH)D on islet β-cells function in the elderly with type 2 diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1021-1026.
|
| [8] |
ZHAO Hailing, ZHANG Haojun, ZHAO Tingting, YAN Meihua, DONG Xi, MA Liang, LI Ping.
Association between the polymorphism of PNPLA2 gene and the risk of ischemic stroke in type 2 diabetic patients in Chinese Han Population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 664-669.
|
| [9] |
HUANG Hao, XIAO Fang, JIA Hong, WANG Xiaoshuang, DUAN Yating.
miR-138-5p protects β cell function by regulating HIF-1α in gestational diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 489-497.
|
| [10] |
YE Shengkai, WEN Jie, LIU Weiping, REN Xia, CHEN Haiying, DU Ying, LI Xue, ZHANG Ru, YU Li, ZHANG Biying.
Effects of dapagliflozin on intima-medial thickness of carotid artery in type 2 diabetic mellitus patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 814-819.
|
| [11] |
XU Ming, SHEN Zheng.
Research progress on the mechanism of traditional Chinese insects' medicine treatment of diabetic neurological complications
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 597-600.
|
| [12] |
LI Zhuqing, JU Yinghui, CHEN Qingqing, MA Keke, LI Weiping.
Protective effects of Astragaloside Ⅳ on early kidney damage in diabetes mellitus rats and its mechanisms
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 255-262.
|
| [13] |
ZHANG Chunyan, FAN Xiaodong, QIN Yuan, KONG Wenqiang, ZHOU Chunyang, DU Biao.
Markov model to assess long-term effects of teneligliptin in treatment of type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 65-72.
|
| [14] |
SONG Meiqing.
Effect of metformin on bone mineral density, insulin resistance and cytokines in type 2 diabetes mellitus patients with primary hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 694-698.
|
| [15] |
LIU Chang, JIANG Daoli, LIU Xiaofang, XU Jia, WANG Lijue, WANG Qian, XU Ling, FANG Yi.
Establishment of rat model of type 2 diabetes induced by streptozotocin combined with cerebral ischemic reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 518-525.
|
